Search results for "myocardial infarction."

showing 10 items of 1011 documents

Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue doppler imaging in patients with acute coronary syndrome

2014

Background: No-reflow phenomenon is a complication of myocardial revascularization and it is associated with a worse prognosis. Materials and Methods: A prospective study was carried out enrolling patients with acute myocardial infarction (64 patients, 49 male and 15 female, median age 64.9 ± 10.61 years), both STEMI and NSTEMI, who underwent myocardial revascularization with percutaneous coronary intervention (PCI). TIMI flow and Myocardial Blush Grade (MBG) were assessed at baseline (T0), in addition to tissue Doppler imaging (TDI) and electrocardiogram. Cardiological evaluation was also performed at T1 (one month after PCI) and T2 (every year after revascularization for a mean follow-up …

medicine.medical_specialtyAcute coronary syndromemyocardial blush gradebusiness.industrymedicine.medical_treatmentDiastolePercutaneous coronary interventionAcute myocardial infarctionRevascularizationmedicine.diseaseInternal medicineConventional PCINo reflow phenomenonCardiologymedicineOriginal ArticleRadiology Nuclear Medicine and imagingMyocardial infarctionno reflowCardiology and Cardiovascular Medicinebusinessmyocardial perfusiontissue doppler imagingTIMIJournal of Cardiovascular Echography
researchProduct

Is neural network better than logistic regression in death prediction in patients after ST-segment elevation myocardial infarction?

2021

Background: There is a need to develop patient classification methods to adjust post-discharge care, improving survival after ST-segment elevation myocardial infarction (STEMI). Aims: The study aimed to determine whether a neural network (NN) is better than logistic regression (LR) in mortality prediction in STEMI patients. Material and methods: The study included patients from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Patients with the first anterior STEMI treated with the primary percutaneous coronary intervention (pPCI) of the left anterior descending (LAD) artery between 2009 and 2015 and discharged alive were included in the study. Patients were randomly divided into th…

medicine.medical_specialtyAcute coronary syndromeneural networkmedicine.medical_treatmentAftercareLogistic regressionSTEMIPercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineHumansST segmentIn patientMyocardial infarctionReceiver operating characteristicArtificial neural networkbusiness.industryPercutaneous coronary interventionpredictionmedicine.diseasePatient DischargeLogistic ModelsTreatment Outcomemyocardial infarctionCardiologyST Elevation Myocardial InfarctionNeural Networks ComputerCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.

2021

Abstract Aims Peripheral artery disease (PAD) patients suffer a high risk of major cardiovascular (CV) events, with athero-thrombo-embolism as the underlying pathophysiologic mechanism. Recently, two large randomized clinical trials evaluated the efficacy and safety of low-dose rivaroxaban twice daily plus aspirin in stable PAD outpatients and those immediately after peripheral revascularization. We sought to determine if the effects of low-dose rivaroxaban and aspirin compared to aspirin alone are consistent across this broad spectrum of PAD patients. Methods and results We conducted a random-effects meta-analysis of the COMPASS and VOYAGER randomized trials among 11 560 PAD patients (4996…

medicine.medical_specialtyAcute limb ischaemiaEpidemiologymedicine.medical_treatmentHemorrhageRevascularizationlaw.inventionBrain IschemiaPeripheral Arterial DiseaseRandomized controlled trialFibrinolytic AgentsRivaroxabanlawIschemiaInternal medicineMedicineHumansMyocardial infarctionAspirinRivaroxabanAspirinbusiness.industryHazard ratiomedicine.diseaseStrokeAmputationCardiologyDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsEuropean journal of preventive cardiology
researchProduct

Cardiovascular effects of nocturnal aircraft noise on healthy volunteers

2013

Background: Nighttime aircraft noise can impair sleep quality and may also increase blood pressure and the risk for myocardial infarction for persons in highly noise exposed residential areas. Pathophysiology and possible susceptibility factors for cardiovascular effects of aircraft noise remain unclear. Methods and results: 75 healthy volunteers (mean age 26 y) were studied for three nights in their homes. One control pattern without noise (Control) and two noise patterns with 30 (Noise 30) or 60 (Noise 60) aircraft noise events were played back in random and blinded order. After each study night flow-mediated dilatation (FMD) of the brachial artery was measured the following the morning. …

medicine.medical_specialtyAircraft noisebusiness.industrymedicine.diseaseNoiseBlood pressureInternal medicinemedicine.arteryHeart ratemedicineCardiologyHeart rate variabilityMyocardial infarctionBrachial arteryCardiology and Cardiovascular MedicinebusinessMorningEuropean Heart Journal
researchProduct

High-Sensitivity Procalcitonin (hs-PCT): A Marker for Identification of Arteriosclerosis and Myocardial Infarction?

2008

Background: Procalcitonin (PCT) is a protein hormone induced by bacterial inflammation that serves as a marker of sepsis. C-reactive protein (CRP) is also known to be a marker of inflammation and, in low concentrations, a prognostic marker for latent or early arteriosclerosis. Arteriosclerosis is considered as an inflammatory process that begins in the wall of an artery. In addition to CRP, the concentration of other markers of inflammation increases in the presence of arteriosclerosis. Methods: To determine if PCT is among these markers, the serum concentration of PCT was quantified in blood samples from healthy individuals (n = 410) and at admission in 774 patients, 92 with peripheral art…

medicine.medical_specialtyAortaAcute coronary syndromebusiness.industryBiochemistry (medical)Clinical BiochemistryIschemiaArteriosclerosismedicine.diseaseProcalcitoninSepsismedicine.anatomical_structureInternal medicinemedicine.arterymedicineCardiologyMyocardial infarctionbusinesshormones hormone substitutes and hormone antagonistsArteryLaboratory Medicine
researchProduct

Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease

2021

Background: In patients with peripheral artery disease (PAD), the impact of diabetes mellitus (DM) on patient-profile and adverse in-hospital events is not well investigated. Methods: The German nationwide inpatient sample 2005–2019 was used for this analysis. Hospitalized PAD patients were stratified for DM and the influence of DM on patient-profile and adverse in-hospital events was investigated. Results: Our study comprised 2,654,871 hospitalizations (54.3% aged ≥70 years, 36.7% females) of patients with PAD in Germany 2005–2019. Among these, 864,691 (32.6%) patients had DM and 76,716 (2.9%) died during hospitalization. Diabetic PAD patients revealed an aggravated cardiovascular profile …

medicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentRGeneral MedicineDiseasemedicine.diseaseperipheral artery diseaseArticlemyocardial infarctionHospital outcomesAmputationInternal medicineDiabetes mellitusamputationdiabetes mellitusmedicinePatient profileMedicineMyocardial infarctionAdverse effectbusinessJournal of Clinical Medicine
researchProduct

COVID ‐19, thromboembolic risk, and Virchow's triad: Lesson from the past

2020

Abstract COronavirus Infectious Disease which started in 2019 (COVID‐19) usually presents with the signs and symptoms of pneumonia. However, a growing number of recent reports highlight the fact that the infection may be by far more than only a respiratory disease. There is evidence of an increased thromboembolic risk in COVID‐19 patients, with a variety of manifestations in terms of ischemic stroke, deep vein thrombosis, acute pulmonary embolism, acute myocardial infarction, systemic arterial embolism, and placental thrombosis. The German physician Rudolph Virchow, about two centuries ago, described three pivotal factors contributing together to thromboembolic risk: endothelial injury, hyp…

medicine.medical_specialtyArterial embolismDeep veinReviewsReviewBlood stasis030204 cardiovascular system & hematologySARS‐CoV‐203 medical and health sciences0302 clinical medicineCOVID‐19medicine030212 general & internal medicineMyocardial infarctionIntensive care medicinebusiness.industryGeneral Medicineendothelial injurythromboembolismmedicine.diseaseThrombosisPulmonary embolismblood stasishypercoagulabilitymedicine.anatomical_structureInfectious disease (medical specialty)Cardiology and Cardiovascular MedicinebusinessVirchow's triadClinical Cardiology
researchProduct

New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction

2015

International audience; Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the general population and contributes not only to a major deterioration in quality of life but also to an increase in cardiovascular morbimortality. The onset of AF in the acute phase of myocardial infarction (MI) is a major event that can jeopardize the prognosis of patients in the short-, medium- and long-term, and is a powerful predictor of a poor prognosis after MI. The suspected mechanism underlying the excess mortality is the drop in coronary flow linked to the acceleration and arrhythmic nature of the left ventricular contractions, which reduce the left ventricular ejection fraction. The p…

medicine.medical_specialtyAsymmetric dimethylarginineSurveillance ECG en continueAsymétrique diméthylargininePopulationMyocardial InfarctionInfarctus du myocardeAcute myocardial infarctionSudden deathContinuous ECG monitoringVentricular Function Left[SHS]Humanities and Social SciencesHeart RateRisk FactorsInternal medicineCoronary CirculationHeart rateAtrial FibrillationmedicinePronosticHumansMyocardial infarctionHospital MortalityeducationHeart FailureFibrillation atriale silencieuseeducation.field_of_studyEjection fractionbusiness.industryAtrial fibrillationStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionOxidative StressSilent atrial fibrillationHeart failureAsymptomatic DiseasesCardiologyEndothelium Vascular[SHS] Humanities and Social SciencesbusinessCardiology and Cardiovascular Medicine
researchProduct

Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insight…

2020

Background: The benefits and risks of blood transfusion in patients with acute myocardial infarction who are anemic or who experience bleeding are debated. We sought to study the association between blood transfusion and ischemic outcomes according to haemoglobin nadir and bleeding status in patients with NST-elevation myocardial infarction (NSTEMI).Methods: The TAO trial randomized patients with NSTEMI and coronary angiogram scheduled within 72h to heparin plus eptifibatide versus otamixaban. After exclusion of patients who underwent coronary artery bypass surgery, patients were categorized according to transfusion status considering transfusion as a timevarying covariate. The primary isch…

medicine.medical_specialtyBlood transfusionAnemiamedicine.medical_treatmentpercutaneous coronary intervention.EptifibatideHemorrhage610 Medicine & healthpercurancous coronary intervention030204 cardiovascular system & hematologyOtamixaban11171 Cardiocentro Ticino2705 Cardiology and Cardiovascular Medicinelaw.invention03 medical and health sciencesCoronary artery bypass surgerychemistry.chemical_compoundPercutaneous Coronary Intervention0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeNon ST elevation Myocardial Infarction[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryBlood transfusionPercutaneous coronary interventionAnemiamedicine.disease3. Good healthTreatment OutcomechemistryEptifibatideCardiology and Cardiovascular Medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

The Role of Cardiac Pacing in Heart Block Complicating Acute Myocardial Infarction

1983

The organization of the Coronary Care Unit and the use of electrocardiographic monitoring have allowed a re-evaluation of the incidence of the atrioventricular conduction disturbances in acute myocardial infarction.

medicine.medical_specialtyCardiac pacingHeart blockbusiness.industryIncidence (epidemiology)Electrocardiography in myocardial infarctionmedicine.diseaseInternal medicinecardiovascular systemmedicineCardiologyCoronary care unitcardiovascular diseasesMyocardial infarctionbusinessAtrioventricular conduction disturbancesAtrioventricular block
researchProduct